Abstract:Abstract Skeletal development is orchestrated by the interaction of the parathyroid hormone related peptide (PTHrP) with the parathyroid hormone receptor type 1 (PTH1R). Knock-out or severe deficiency of either PTH1R or PTHrP by homozygous loss-of-function mutations results in premature hypertrophy of chondrocytes and accelerated bone mineralization, leading to neonatal death. In contrast, patients with a heterozygous gain-of-function PTH1R mutation (H223R, T410P/R or I458K/R) present with Jansen metaphyseal chondrodysplasia (JMC), characterized by delayed bone mineralization, hypercalcemia, hypercalciuria and hypophosphatemia. Eiken syndrome is also characterized by markedly delayed bone mineralization but lacks the biochemical abnormalities of JMC. Eiken syndrome has been described for three unrelated families, in which there are one of three homozygous PTH1R mutations: R485X, E35K or Y134S. As the functional properties of these PTH1R mutants have not been studied, we assessed their characteristics in cell-based assays. GS22A cells (HEK293/Glosensor) were transiently transfected to express the WT or a mutant PTH1R. Cell surface expression levels assessed by extracellular HA tag-directed immunofluorescence flow cytometry and normalized to PTH1R-WT (100%) were 50% for PTH1R-R485X, 90% for PTH1R-E35K and 20% for PTH1R-Y134S. Dynamic cAMP measurements via the Glosensor reporter revealed that the basal activities of PTH1R-R485X and PTH1R-E35K were 7-fold and 1.5-fold higher than that of PTH1R-WT (p<0.005), while that of PTH1R-Y134S was comparable to PTH1R-WT. Stimulation with PTH(1-34) or PTHrP(1-36) yielded similar cAMP potencies for the three mutants and PTH1R-WT (EC50s ∼ 0.5 nM, p >0.05). Intracellular calcium signaling assessed by changes in FURA2 fluorescence after PTHrP(1-36) (100 nM) addition was more robust with PTH1R-R485X than for PTH1R-WT (AUCs over 2.5 mins. = 606±9 vs 551±10, p=0.0074) and similar to PTH1R-WT with PTH1R-E35K and PTH1R-Y134S (p ≥0.2). Both basal and agonist-activated cAMP signaling by the R485X mutant were reduced by addition of a dTrp12-PTHrP(7-36) antagonist/inverse agonist analog. Fluorescence microscopy of HEK293/βarrestin2YFP (GBR24) cells stimulated with TMRPTH(1-34) revealed a clear association of βarrestin2YFP with PTH1R-WT, as well as with PTH1R-E35K and PTH1R-Y134S in internalized complexes, but no such association with PTH1R-R485X. Nevertheless, over-expression of βarrestin2YFP in GS22A cells markedly reduced basal and ligand-stimulated cAMP generation by PTH1R-R485X, consistent with a residual capacity of PTH1R-485X to bind βarrestin2. Treatment with the endocytosis inhibitor Dyngo4A in GS22A cells transfected with PTH1R-R485X completely blocked TMRPTH(1-34) internalization assessed by fluorescent microscopy, and enhanced ∼5-fold the cAMP response potency to PTH(1-34) vs DMSO treatment. In contrast, treatment with Dyngo4A did not increase PTH(1-34) cAMP potency in the PTH1R-WT. Collectively these results suggest that PTH1R-R485X signals via cAMP predominantly from the cell surface. The data reveal distinct functional properties for the three PTH1R mutants associated with Eiken syndrome and suggest a novel correlation between excessive PTH1R cAMP signaling due to impaired βarrestin-mediated internalization and a delay in ossification. Presentation: Monday, June 13, 2022 11:30 a.m. - 11:45 a.m.

Fluorescent Ligand-Directed Co-Localization of the Parathyroid Hormone 1 Receptor with the Brush-Border Scaffold Complex of the Proximal Tubule Reveals Hormone-Dependent Changes in Ezrin Immunoreactivity Consistent with Inactivation.

Structure and Dynamics of the Active Human Parathyroid Hormone Receptor-1.

Structural Basis of Activation and Sustained Signaling by the PTH Receptor

Parathyroid Hormone Controls Paracellular Ca 2+ Transport in the Thick Ascending Limb by Regulating the Tight-Junction Protein Claudin14

Parathyroid Hormone-Potentiated Connective Tissue Growth Factor Expression In Human Renal Proximal Tubular Cells Through Activating The Mapk And Nf-Kappa B Signalling Pathways

Quantitative Analysis of Agonist-Dependent Parathyroid Hormone Receptor Trafficking in Whole Cells Using A Functional Green Fluorescent Protein Conjugate

OR21-3 Spatial Signaling Bias of a Gain-of-Function PTH1R Mutant Associated with Delayed Ossification in Eiken Syndrome

Expression Of Pthrp, Pth/Pthrp Receptor, And Ca2+-Sensing Receptor Mrnas Along The Rat Nephron

Unraveling the Interplay of Extracellular Domain Conformational Changes and Parathyroid Hormone Type 1 Receptor Activation in Class B1 G Protein-Coupled Receptors: Integrating Enhanced Sampling Molecular Dynamics Simulations and Markov State Models

Visualization of the Parathyroid Hormone Receptor in Long-Active States

Distinct and overlapping RGS14 and RGS12 actions regulate NPT2A-mediated phosphate transport

Critical Extracellular Ca2+ Dependence of the Binding Between PTH1R and a G-Protein Peptide Revealed by MD Simulations.

Specific Inhibition of Long-Lasting, L-type Calcium Channels by Synthetic Parathyroid Hormone.

Activation of A Non-Camp/Pka Signaling Pathway Downstream of the Pth/Pthrp Receptor is Essential for A Sustained Hypophosphatemic Response to Pth Infusion in Male Mice

Parathyroid Hormone-Related Protein Regulates Osteoclast Inhibitory Lectin Expression Via Multiple Signaling Pathways in Osteoblast-Like Cells.

Parathyroid Hormone Induces Epithelial-to-mesenchymal Transition Via the Wnt/β-catenin Signaling Pathway in Human Renal Proximal Tubular Cells.

Expression of connective tissue growth factor induced by parathyroid hormone via MAPK signaling pathway in human renal proximal tubular cells

Molecular insights into differentiated ligand recognition of the human parathyroid hormone receptor 2

Parathyroid Hormone 1 Receptor Is Essential To Induce Fgf23 Production And Maintain Systemic Mineral Ion Homeostasis

Immunolocalization of Enzymes/Membrane Transporters Related to Bone Mineralization in the Metaphyses of the Long Bones of Parathyroid-Hormone-Administered Mice.

Molecular insights into the distinct signaling duration for the peptide-induced PTH1R activation